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Negative feedback processes, which can enable maintenance of neuronal 
homeostasis, are widely observed in neuronal systems1-3.  For example, neuronal 
silencing via tetrodotoxin application both in vivo and in vitro increases excitability4-6.  
This effect occurs in vitro via both increased sodium currents and decreased potassium 
currents.  However, the signalling pathways responsible for these excitability changes 
remain unclear.  The mammalian type II metabotropic glutamate receptors, which are G-
protein coupled receptors activated by glutamate, are well positioned to mediate negative 
feedback.  When localized presynaptically, these receptors can act as autoinhibitors of 
glutamate release7-10.  Because these receptors are located outside of the active zone11, 
activation is thought to occur only during conditions of elevated glutamate release and 
might serve to prevent glutamate-mediated neurotoxicity.  Agonists for these receptors 
are proposed for treatment of schizophrenia, anxiety and epilepsy, among others12, 13, but 
although many of the acute effects of type II mGluR activation on neuronal physiology 
have been elucidated14, 15, possible long term effects on neuronal function, such as 
through changes in ion channel gene expression, remain essentially unexplored. 
The Drosophila mGluRA affects the rate of onset of long-term facilitation 
(LTF), a reporter for motor neuron excitability:  In Drosophila, the single mGluRA 
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gene encodes a protein most similar to the mammalian type II mGluR16.  mGluRA is 
located presynaptically at the neuromuscular junction (nmj), which suggests that 
mGluRA might regulate transmitter release from motor neurons.  Elimination of mGluRA 
by the null mutation mGluRA112b affects a form of synaptic plasticity termed long-term 
facilitation (LTF)16, 17, which is induced when a motor neuron is subjected to repetitive 
nerve stimulation at low bath [Ca2+].  At a certain point in the stimulus train, an abrupt 
increase in transmitter release and hence muscle depolarization (termed excitatory 
junctional potential, or ejp) is observed (Figure 1A).  This abrupt increase is caused by an 
abrupt increase in the duration of nerve terminal depolarization and hence Ca2+ influx,  
and reflects a progressive increase in motor neuron excitability induced by the repetitive 
nerve stimulation:  when an excitability threshold is reached, LTF occurs17-19.   
In Drosophila, many genotypes that increase motor neuron excitability by 
decreasing K+ currents or increasing Na+ currents increase the rate of onset of LTF.  For 
example, altered activities of frequenin and Hyperkinetic, which act via K+ channels, or 
paralytic and pumilio, which act via Na+ channels, each increase the rate of onset of 
LTF18-25.  By increasing motor neuron excitability, these genotypes apparently bring 
excitability closer to the threshold required to evoke LTF and consequently decrease the 
number of prior nerve stimulations required to reach this threshold. The observation that 
mGluR112b increases the rate of onset of LTF suggested that mGluR112b increases motor 
neuron excitability as well16. 
Glutamate-activation of mGluRA decreases neuronal excitability by 
preventing PI3K activation:  In addition to increasing neuronal excitability, mGluR112b 
also decreased arborization and synapse number at the larval neuromuscular junction16.  
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This phenotype is also observed in larval motor neurons with decreased activity of 
PI3K26. This observation raised the possibility that mGluRA might exert its effects on 
both synapse formation and neuronal excitability via PI3K activity.  To test this 
possibility, we used the Gal4/UAS system27 to overexpress transgenes expected to alter 
activity of the motor neuron PI3K pathway.  We found that inhibiting the PI3K pathway 
by motor neuron specific overexpression of either the phosphatase PTEN, which opposes 
the effect of PI3K, or the dominant-negative PI3KDN 28, each significantly increased the 
rate of onset of LTF, similarly to that of mGluRA112b (Figure 1A and 1B).  In contrast, we 
found that activating the PI3K pathway by expression of the constitutively active PI3K-
CAAX 28, or via RNAi-mediated inhibition of PTEN decreased rate of onset of LTF 
(Figure 1A and 1B).  These observations support the notion that loss of mGluRA 
increases motor neuron excitability by preventing the activation of the PI3K pathway.  A 
role for type II mGluRs in PI3K pathway activation, and for the PI3K pathway in the 
control of neuronal excitability, are each novel findings. 
In addition to effects on LTF, mutations that alter motor neuron excitability can  
alter basal transmitter release and hence ejp amplitude at low bath Ca2+ concentrations, at 
which Ca2+ influx would be limiting for vesicle fusion to occur.  For example, mutations 
in ether-a go-go (eag), which encodes a potassium channel α subunit, increase 
transmitter release about two-fold29, whereas a mutation in the sodium channel gene 
paralytic decreases transmitter release by increasing the frequency of failures of vesicle 
release30.  Presumably altered excitability affects the amplitude or duration of the action 
potential and consequently the amount of Ca2+ influx through voltage-gated channels.  
We found that mGluRA112b also increased ejp amplitude and hence basal transmitter 
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release at three low bath Ca2+ concentrations tested (Figure 1C), which is consistent with 
increased motor neuron excitability in this genotype.   To test if altering the PI3K 
pathway would similarly affect basal transmitter release, we compared ejp amplitudes in 
larvae with altered activity of the PI3K pathway in motor neurons.  We found that 
decreasing PI3K pathway activity via motor neuron overexpression of PI3KDN or PTEN 
increased transmitter release to levels similar to mGluRA112b, whereas increasing PI3K 
pathway activity via overexpression of PI3K-CAAX decreased basal transmitter release 
(Figure 1C).  
The mGluRA112b mutation also decreased the frequency at which failures of 
vesicle release occur, particularly at the lower Ca2+ concentrations tested (Supplementary 
Figure 1B).  This observation confirms that the effect of mGluRA112b on ejp amplitude is 
presynaptic.  We also observed a decreased frequency of failures when the PI3K pathway 
was inhibited by motor neuron expression of PI3KDN or PTEN (Supplementary Figure 
1A).  In contrast, motor neuron overexpression of PI3K-CAAX increased the frequency of 
failures (Supplementary Figure 1A). Therefore, with three electrophysiological readouts, 
the mGluRA112b mutant phenotype was mimicked by decreased activity of the PI3K 
pathway, whereas increasing PI3K pathway activity conferred opposite effects. 
The effects of PI3K on neuronal excitability are mediated by Foxo, not 
Tor/S6 kinase:  Many effects of the PI3K pathway are mediated by the downstream 
kinase Akt.  Activated Akt phosphorylates and inhibits targets such as Tsc1/Tsc2, which 
regulates cell growth via the Tor/S6 Kinase (S6K) pathway31, Foxo, which regulates 
apoptosis32, and GSK333, which mediates at least in part the effects of altered PI3K 
pathway activity on arborization and synapse formation26.  To determine if the Tor/S6K 
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pathway mediates the effects of altered PI3K pathway activity on neuronal excitability, 
we tested the effects of overexpression of either the dominant-negative S6KDN or the 
constitutively active S6KAct transgene34 in motor neurons.  We found that the rate of onset 
of LTF was unaffected by expression of both transgenes (Figure 1D), and that expression 
of S6KDN had no effect on the ability of PI3K-CAAX to decrease the rate of onset of LTF 
(Figure 1D).  Furthermore, expression of S6KDN had no effect on basal transmitter 
release, and did not affect the ability of PI3K-CAAX to depress basal transmitter release 
(data not shown).  Therefore we conclude that the Tor/S6K pathway does not mediate the 
effects of PI3K on neuronal excitability. 
To determine if Foxo mediates the effects of altered PI3K pathway activity on 
neuronal excitability, we measured the rate of onset of LTF in larvae carrying the 
heteroallelic Foxo21/Foxo25 null mutant combination35 and in larvae overexpressing 
Foxo+ 36 in motor neurons.  We found that overexpression of Foxo+ increased the rate of 
onset of LTF to a level very similar to that observed when PI3K pathway activity was 
decreased (Figure 1D), whereas in Foxo21/Foxo25 larvae, both the rate of onset of LTF 
and basal transmitter release were decreased, and the frequency of failures increased, to 
levels very similar to those observed when PI3K pathway activity was increased (Figure 
1C, Figure 1D and Supplementary Figure 1B).  These results are consistent with the 
possibility that the effects of increased PI3K activity on neuronal excitability are 
mediated entirely by Foxo inhibition. 
The effects of PI3K on synapse formation are mediated by Tor/S6 kinase, not 
Foxo:  Because altered PI3K pathway activity alters motor neuron arborization and 
synapse formation26, it seemed possible that a causal relationship existed between the 
 6
PI3K-mediated excitability and neuroanatomy defects.  To test this possibility, we 
evaluated the roles of the Tor/S6K and Foxo pathways in mediating the effects of altered 
PI3K activity on synapse formation. We found that motor neuron-specific expression of 
S6KAct increased bouton number to an extent similar to PI3K-CAAX, and  motor neuron 
expression of S6KDN decreased bouton number to the same extent as PI3KDN while also 
partially suppressing the increase in bouton number conferred by PI3K-CAAX 
(Supplementary Figure 2).  This partial suppression suggests that both Tor/S6K and a 
second, PI3K-mediated, pathway (presumably involving GSK3) regulate synapse 
formation.  In contrast to the effects of altered S6K on synapse formation, we found that 
Foxo+ overexpression had no effect on synapse number (data not shown) and failed to 
suppress the growth-promoting effects of PI3K-CAAX (Supplementary Figure 2).   
The PI3K pathway also affects growth along the length of axons and thus 
regulates axon diameter.  In Drosophila peripheral nerves, about 80 motor and sensory 
axons are wrapped by about three layers of glia, as shown in the transmission electron 
micrograph from cross sections of peripheral nerves in Supplementary Figure 2C.  We 
found that motor neuron specific expression of PTEN decreased axon diameter, whereas 
motor-neuron specific expression of PI3K-CAAX increased axon diameter. Tor/S6K, but 
not Foxo, mediates this growth effect.  In particular, motor neuron-specific expression of 
S6KAct increased axon diameter to an extent similar to PI3K-CAAX, and motor-neuron-
specific expression of S6KDN decreased motor axon diameter to an extent similar to 
PTEN and also partially suppressed the growth-promoting effects conferred by PI3K-
CAAX.  In contrast, Foxo+ overexpression had no effect on the ability of PI3K-CAAX to 
increase axon diameter (Supplementary Figure 2D).  Therefore, Foxo mediates the 
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excitability effects, but not the growth-promoting effects, of altered PI3K pathway 
activity.  We conclude that the excitability and growth effects are completely separable 
genetically and thus have no causal relationship. 
Epistasis tests among mGluRA, PI3K and Foxo support a model for the 
glutamate-induced negative feedback regulation of neuronal excitability:  The effects 
on neuronal excitability of altered mGluRA, PI3K, and Foxo activities are consistent with 
a model in which glutamate released from motor nerve terminals as a consequence of 
motor neuron activity activates motor neuron PI3K via mGluRA autoreceptors, which 
then downregulate neuronal excitability via inhibition of Foxo (Figure 2).  Foxo, in turn, 
might regulate excitability via transcription of ion channel subunits or regulators.  This 
model predicts the outcomes of several epistasis tests.  First, the hyperexcitability of 
mGluRA112b is predicted to result from low PI3K activity.  If so, then motor neuron 
expression of PI3K-CAAX will suppress this hyperexcitability.  We found that larvae 
expressing PI3K-CAAX in an mGluRA112b background exhibited a rate of onset of LTF, 
basal transmitter release, and failure frequency very similar to what was observed when 
PI3K-CAAX was expressed in a wildtype background (Supplementary Figure 1 and 
Supplementary Figure 3).  Second, the hyperexcitability conferred by motor neuron 
expression of PI3KDN is predicted to result from Foxo+ hyperactivity.  If so, then the 
absence of Foxo protein will suppress this hyperexcitability.  We found that larvae 
carrying the Foxo21/Foxo25 null combination and expressing PI3KDN in motor neurons 
exhibited a rate of onset of LTF, basal transmitter release, and failure frequency very 
similar to what was observed in the Foxo21/Foxo25 null mutant alone (Figure 3 and 
Supplementary Figure 1).  Third, the hypoexcitability conferred by motor neuron 
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expression of PI3K-CAAX is predicted to result from decreased Foxo activity.  If so, then 
Foxo+ overexpression will suppress this hypoexcitability.  We found that larvae co-
expressing Foxo+ and PI3K-CAAX in motor neurons exhibited basal transmitter release 
and failure frequency very similar to what was observed when PI3KDN or PTEN alone 
were expressed in motor neurons (Figure 3 and Supplementary Figure 1), and the rate of 
onset of LTF was very similar to what was observed when Foxo+ alone was expressed in 
motor neurons  (Figure 1D and Figure 3).  Fourth, the hyperexcitability conferred by 
mGluRA112b is predicted to result from Foxo hyperactivity.  If so, then the absence of 
Foxo protein will suppress this hyperexcitability.  We found that basal transmitter release 
and failure frequency in Foxo21/Foxo25 ;  mGluRA112b larvae were very similar to what 
was observed in Foxo21/Foxo25 ;  mGluRA+ (Supplementary figure 1 and Supplementary 
Figure 3) and rate of onset of LTF was also significantly, but partially, suppressed 
(Supplementary figure 3).  This observation supports the notion that glutamate-activation 
of mGluRA decreases neuronal excitability by decreasing Foxo+ activity, but the ability 
of Foxo21/Foxo25 to suppress the mGluRA112b LTF phenotype only partially raises the 
possibility that mGluRA might also regulate neuronal excitability in a Foxo-independent 
manner.  The model shown in Figure 2 is strongly supported by the ability of the model 
to predict successfully the results of these epistasis tests. 
Glutamate application increases motor nerve terminal phospho-Akt levels in 
an mGluRA-dependent fashion:  Next we wanted to test directly the prediction that 
glutamate activates PI3K via mGluRA autoreceptors within motor neurons.  To assay for 
PI3K activity, we applied an antibody specific for the phosphorylated form of Akt (p-
Akt), which is increased by elevated PI3K pathway activity.  The ability to detect p-Akt 
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in larval motor neurons overexpressing PI3K-CAAX, but not in wildtype (Figure 4), 
validates this antibody as a PI3K reporter. 
To determine if glutamate application would activate PI3K in motor nerve 
terminals, we compared p-Akt levels in wildtype versus mGluRA112b motor nerve 
terminals immediately prior to or following a 1 minute application of 100 µM glutamate.  
We found that glutamate application strongly increased p-Akt levels in wildtype larvae, 
but not in the mGluRA112b larvae (Figure 4), demonstrating that glutamate application 
increases nerve terminal p-Akt levels, and that mGluRA activity is required for this 
increase.  To determine if mGluRA activity was required presynaptically for this p-Akt 
increase, we knocked down mGluRA levels specifically in the motor neuron via motor 
neuron-specific expression of an mGluRA RNAi construct, which was previously shown 
to decrease mGluRA levels successfully16.  We found that motor neuron specific 
knockdown of mGluRA, or motor neuron-specific expression of PI3KDN, significantly 
inhibited the ability of glutamate to increase p-Akt levels (Figure 4).  Thus, presynaptic 
mGluRA and PI3K activity are both necessary for glutamate to increase p-Akt. 
Activity-dependent increase in synapse formation requires PI3K activity:  
Depending on the system, neuronal activity can either restrict or promote synapse 
formation37.  The Drosophila eag Sh double mutant, in which two distinct potassium 
channel subunits are simultaneously disrupted, displays extreme neuronal 
hyperexcitability29, and a consequent increase in synapse number38.  This activity-
dependent increase in synapse formation does not require mGluRA activity16, suggesting 
that excessive glutamate release is not necessary for this excessive growth to occur.  To 
determine if PI3K activity is required for this overgrowth, we compared synapse number 
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in wildtype larvae, in larvae expressing dominant-negative transgenes for both eag 
(eagDN) and Sh (ShDN)39, 40  in motor neurons, and in larvae co-expressing eagDN, ShDN 
and PI3KDN.  We found that co-expression of eagDN and ShDN in motor neurons increased 
synapse number similarly to what was observed previously38, and that this increase was 
completely blocked by simultaneous expression of PI3KDN but not by lacZ (Figure 5).  
Thus, the activity-dependent increase in synapse formation requires PI3K activity.  The 
observation that glutamate activation of mGluRA is not necessary for this increase raises 
the possibility that another PI3K activator contributes to synapse formation at the larval 
nmj.  Insulin is a plausible candidate for such an activator because both insulin and 
insulin receptor immunoreactivity are present at the nmj41. 
Other negative feedback systems at the Drosophila nmj:  The mGluRA-
dependent negative feedback reported here co-exists with several other negative feedback 
systems operating at the Drosophila nmj.  In addition to altered excitability, these systems 
include alterations in the vesicle release properties of the motor nerve terminal and 
density of the muscle glutamate receptors1.  Presumably, these diverse feedback systems 
regulate specific aspects of neuronal function.  For example, the mGluRA-dependent 
feedback system reported here might protect neurons from excitotoxic effects of 
prolonged stimulation; such protection would not be accomplished by the other feedback 
systems operating.  In addition, because the mGluRA-dependent feedback apparently 
involves transcriptional changes, the system is expected to operate on a long time scale 
(minutes to hours) and thus be responsive to chronic, rather than acute, changes in 
neuronal activity. 
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Neuronal excitability in human disease: Human orthologues of the molecules 
described here are implicated in several neurological disorders.  For example, type II 
mGluRs are potential drug targets for schizophrenia, epilepsy, and anxiety disorders12-14, 
raising the possibility that altered excitability of glutamatergic neurons might play a role 
in these disorders.  In addition, levels of phospho-Foxo, a product of PI3K/Akt activity, 
are increased following induction of seizures in rats, and in the hippocampi of epileptic 
patients42.  This activity-induced increase in phospho-Foxo was interpreted as a 
mechanism to protect neurons from the excitotoxic effects of excessive glutamate release 
because Foxo, but not phospho-Foxo, can promote apoptosis.  Our results raise the 
possibility that this increased phospho-Foxo occurs via glutamate-induced PI3K 
activation mediated by type II mGluRs, and interpret this increase as a negative feedback 
on excitability.  These interpretations are not mutually exclusive.  Increased insulin/IGF 
levels and increased PI3K activity are also implicated in autism spectrum disorders43, 44.  
These increases are generally hypothesized to affect neuronal function by increasing 
arborization and synapse formation, but our results raise the possibility that altered 
neuronal excitability might also contribute.  Finally, increased PI3K activity is implicated 
in nervous system tumors occurring in individuals with the genetic disorder type 1 
Neurofibromatosis45-47.  Our results raise the possibility that learning disabilities 
associated with this disease might involve PI3K-dependent alterations in neuronal 
excitability.  Thus, the results reported here might have significance for several human 
neurological disorders.  
A novel signalling pathway linking type II mGluRs and PI3K:  The 
mechanism by which glutamate-activated mGluRA activates PI3K remains unknown.  
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Although mammalian type I mGluRs activate PI3K via the Homer scaffolding protein 
and the PI3K enhancer PIKE48, Drosophila mGluRA, similar to mammalian type II 
mGluRs, lack Homer binding motifs49 and thus would not be predicted to activate PI3K 
by this mechanism.  Alternatively, although the inhibition of glutamate-induced p-Akt 
activation by PI3KDN expression demonstrates that PI3K activity is required for this 
activation, it remains possible that glutamate increases p-Akt levels by activating an 
enzyme in addition to PI3K.  For example, Akt is reported to be phosphorylated and 
activated by Calmodulin-dependent kinase kinase50.  Further experiments will be required 
to address these issues. 
 
Methods 
 
Drosophila Stocks:  Fly stocks were maintained on standard cornmeal/ agar Drosophila 
media at room temperature.  D42 and OK6 express Gal4 in motor neurons and were 
provided by Tom Schwarz, Boston, Massachusetts, and Hermann Aberle, Tubingen, 
Germany respectively.  The UAS-PI3KDN (D954A) and UAS-PI3K-CAAX transgenes 
were provided by Sally Leevers, London, UK, the UAS-Foxo+ transgene was provided by 
Marc Tatar, Providence, RI, the Foxo21 and Foxo25 lines were provided by Heinrich 
Jasper, Rochester, NY, the UAS-S6KDN  and UAS-S6Kact transgenes were provided by 
Ping Shen, Athens, GA, and the UAS-mGluRARNAi and the mGluRA112b lines were 
provided by Marie-Laure Parmentier, Montpelier, France.  All other fly stocks were 
provided by the Drosophila stock center, Bloomington, IN. 
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Immunocytochemistry:  FITC conjugated antibodies against horseradish peroxidase 
(HRP) were raised in goat (Jackson ImmunoResearch) and were used at 1:400 dilution.  
Antibodies against Drosophila p-Akt (Ser505) were raised in rabbit (Cell Signaling 
Technologies) and were used at 1:500 dilution.  Rhodamine Red conjugated goat anti-
rabbit (Jackson ImmunoResearch) was used at a dilution of 1:1000.  For arborization 
measurements, larvae were dissected in PBS-T and fixed in 4% paraformaldehyde.  
Images were taken on a Zeiss 410 laser scanning confocal microscope (LSM) with a 20x 
objective. ImageJ was used to obtain surface area measurements of muscle 6 from 
abdominal segment A3, and the number of boutons was counted manually.   For p-Akt 
measurements, larvae were dissected in Grace’s insect cell culture media (Gibco).  When 
glutamate was applied,100 µM glutamic acid monosodium salt monohydrate (Acros 
Organics) dissolved in Grace’s insect cell culture media was added to the well of the 
dissection plate.  1 minute after glutamate addition, larvae were rapidly washed in 
standard saline (0.128 M NaCl, 2.0 mM KCl, 4.0 mM MgCl2, 0.34 M sucrose, 5.0 mM 
HEPES, pH 7.1, and 0.15 mM CaCl2), and then immediately fixed in 4% 
paraformaldehyde. For the 10 min wash, the larvae were washed in Grace’s insect cell 
culture media and placed on shaker for 10 minutes before fixing.  Images were taken on a 
Zeiss 510 LSM with a 20x objective.  Z-stacks were compiled from 2 µm serial sections 
to a depth adequate to encompass the entire bouton thickness for each sample (from 8-20 
µm).  Muscles 7 and 6 from either abdominal segments A3 or A4 were used for 
measurements.  ImageJ software was used to analyze p-Akt intensities. In particular, 2D 
projections were created using the median pixel intensity from each stack at each 
coordinate point.  Neuronal structures, marked by anti-HRP, were traced using the 
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freehand selection tool and the selection was transferred to the anti-p-Akt image where 
the mean pixel intensity value was measured.  Background was obtained with a selection 
box encompassing the non-neuronal area of muscles 6 and 7 in the particular abdominal 
segment, the mean pixel intensity was measured and subtracted from the mean p-Akt 
pixel intensity.  
 
Electrophysiology:  The D42 motor neuron driver was used to express transgenes for all 
experiments, except that the OK6 driver was used for experiments including 
Foxo21/Foxo25.  OK6 behaves indistinguishably from D42 in these assays (not shown) 
and is located on a different chromosome from Foxo, which simplifies stock construction.  
Larvae were grown to the wandering third-instar stage in uncrowded bottles at room 
temperature and dissected as described (17, 18) in standard saline solution (128 mM 
NaCl, 2.0 mM KCl, 4.0 mM MgCl2, 340 mM sucrose, 5.0 mM HEPES, pH 7.1, and 
CaCl2 as specified in the text).  Peripheral nerves were cut posterior to the ventral 
ganglion and were stimulated using a suction electrode.  Muscle recordings were taken 
from muscle 6 in abdominal sections 3-5.   Recording electrodes were pulled using a 
Flaming/Brown micropipette puller to a tip resistence of 10-40 MΩ and filled with 3M 
KCl.   
 
Electron Microscopy:  Larvae were grown to the wandering third-instar stage in 
uncrowded bottles at room temperature.  Dissections and preparation for microscopy 
were performed as previously described (47).  Axon diameter measurements were taken 
from the five largest axons from five different nerves from at least two different larvae. 
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Statistics:  Data are mean ± SEM.  P values are from students two tailed t-tests. 
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Figure Legends 
 
 
Figure 1.  PI3K activity inhibits neuronal excitability by inhibiting the transcription 
factor Foxo.   The motor neuron GAL4 driver D42 was used to drive expression of all 
transgenes.  For all LTF experiments, the bath solution contained 0.15 mM [Ca2+] and 
100 µM quinidine, which is a K+ channel blocker that sensitizes the motor neuron and 
enables LTF to occur and measured even in hypoexcitable neurons.  A, Representative 
traces showing the decreased rate of onset of long-term facilitation (LTF) (I) and 
decreased excitatory junction potential (ejp) amplitude (II) in larvae overexpressing 
PI3K-CAAX in motor neurons compared to wildtype at the indicated [Ca2+], and the 
increased rate of onset of LTF and ejp amplitude in larvae overexpressing PTEN.  
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Arrowheads indicate the increased and asynchronous ejps, indicative of onset of LTF.  In 
(II), ejps are averages of 180 responses for each genotype.  B, D Number of stimulations 
required to induce LTF (Y axis) at the indicated stimulus frequencies (X axis) in the 
indicated genotypes. Geometric means +/- SEMs are shown.  For B, from top to bottom, 
n = 8, 12, 18, 9, and 21, respectively, for each genotype.  For D, from top to bottom, n = 
7, 6, 18, 14, 9, and 7, respectively, for each genotype.  C, Mean ejp amplitudes (Y axis) at 
the indicated [Ca2+] (X axis), from the indicated genotypes.   Larval nerves were 
stimulated at a frequency of 1 Hz, and 10 responses were measured from each of six 
larvae.  Means +/- SEMs are shown.   
 
Figure 2.  A model for the negative feedback loop regulating motor neuron excitability.  
The transcription factor Foxo increases neuronal excitability through a mechanism 
possibly involving transcription of ion channel subunits or regulators.  This increased 
excitability promotes glutamate release from motor nerve terminals, which then activates 
presynaptic DmGluRA in an autocrine manner.  This activation, in turn, activates PI3K 
and the subsequent inactivation of Foxo by Akt-mediated inhibitory phosphorylation. 
Activated PI3K also promotes axonal growth and synapse formation via the Tor/S6K 
pathway. 
 
Figure 3.  A Foxo - PI3K - DmGluR epistasis series in the control of motor neuron 
excitability.  The Gal4 driver D42 was used to drive expression of transgenes in all 
genotypes except for Foxo21/Foxo25;  OK6>PI3KDN, in which the motor neuron driver 
OK6 was used and which behaves similarly to D42 in this assay (not shown).  A, Mean 
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ejp amplitude +/- SEMs (Y axis) for each genotype at the indicated [Ca2+].  Nerves from 
six larvae were stimulated at a frequency of 1 Hz, and 10 responses were measured per 
larva. B, Number of stimulations required to induce LTF (Y axis) at the indicated 
stimulus frequencies (X axis).  The bath solution contained 0.15 mM [Ca2+] and 0.1 mM 
quinidine.  Geometric means +/- SEMs are shown.  From top to bottom, n = 7, 18, and 
10, respectively, for each genotype.   
 
Figure 4.  Glutamate application stimulates presynaptic Akt phosphorylation in 
DmGluRA+ but not in DmGluRA112b mutant larvae.  A, Representative confocal images of 
in DmGluRA+, DmGluRA112b , D42>mGluRARNAi and D42>PI3KDN larvae stained with 
anti-HRP (upper) and anti-p-Akt (lower) in the indicated conditions.  All images are from 
muscles 7 and 6 of abdominal segment A3 or A4.  Scale bar = 20 µm.  B, Quantification 
of phosphorylated Akt (p-Akt) levels in DmGluRA+, DmGluRA112b , D42>mGluRARNAi 
and D42>PI3KDN larvae immediately prior to glutamate application, after 1 min of 100 
µM glutamate application (final bath concentration), and 10 min after a wash with 
glutamate free media.  Nerve terminals were outlined with HRP fluorescence as 
reference. Pixel intensities were quantified using ImageJ software and background 
subtraction was performed as described in detail in Methods section.  Bars represent 
mean synaptic p-Akt levels +/- SEMs. D42 > PI3K-CAAX is included as a positive 
control.   
 
Figure 5.  PI3KDN expression suppresses the synaptic overgrowth conferred by motor 
neuron expression of eagDN and ShDN .  The D42 Gal4 driver was used to induce motor 
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neuron transgene expression.  A, Representative confocal images of muscles 7 and 6 in 
the indicated genotypes.  Larvae were stained with anti-HRP (green).  Scale bar = 20 µm.  
B,  Mean number of synaptic boutons normalized to the surface area (Y axis) of muscle 6 
at abdominal segment A3 in the indicated genotypes (X axis).  From top to bottom, n = 
12, 6, 6 and 6 respectively, for each genotype.   
 
Supplementary Information 
 
 
 
Supplementary Figure 1:  Effects of altered PI3K pathway activity on failures of 
transmitter release.  A,B  Mean transmitter release success rate +/- SEMs (Y axis) at the 
indicated Ca2+ concentration (X axis) for the indicated genotypes.  Larval nerves were 
stimulated at 1 Hz.  10 responses were collected per nerve from each of 6 larvae for the 
given genotype and at the given Ca2+ concentration.   
 
Supplementary Figure 2.  PI3K regulates synapse formation and axon growth via S6K, 
not Foxo.  A, Representative images of muscles 7 and 6 in the indicated genotypes.  
Larva were stained with anti-HRP (green).  Scale bar = 50 µm.  B, Quantification of the 
number of synaptic boutons normalized to the surface area of muscle 6 at abdominal 
segment A3 in the indicated genotypes.  From left to right, n=6,8,6,6,7,6,11, respectively, 
for each genotype.   Data for D42>PI3KDN and D42>+ were taken from Figure 5.  C, 
Representative transmission electron micrographs of peripheral nerve cross sections.  
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Axons are marked with arrows.  Scale bar = 2 µm. D, Quantification of axon diameter for 
the indicated genotypes.  Bars represent the mean of the five largest axons from five 
different nerves (25 measurements total).  Error Bars represent SEMs.  
 
Supplementary Figure 3. A Foxo - PI3K - DmGluR epistasis series in the control of 
motor neuron excitability.  The Gal4 driver D42 was used to drive expression of 
transgenes in all genotypes except for Foxo21/Foxo25;  OK6>PI3KDN, in which the motor 
neuron driver OK6 was used and which behaves similarly to D42 in this assay (not 
shown).  Some of these data were reported in Figure 3 (indicated by hatched lines) and 
are shown here to enable comparisons with additional genotypes.  A, Mean ejp amplitude 
+/- SEMs (Y axis) for each genotype at the indicated [Ca2+].  Nerves from six larvae were 
stimulated at a frequency of 1 Hz, and 10 responses were measured per larva. B, Number 
of stimulations required to induce LTF (Y axis) at the indicated stimulus frequencies (X 
axis).  The bath solution contained 0.15 mM [Ca2+] and 0.1 mM quinidine.  Geometric 
means +/- SEMs are shown.  From top to bottom, n = 7, 7, 18, 6, 10, and 8, respectively, 
for each genotype.   








